Hengrui Liu studied Chinese pharmacology, Chinese materia medical, and biochemistry at Guangzhou University of Chinese Medicine (Guangzhou, China), Jinan University (Guangzhou, China), and the University of Cambridge (UK) respectively. He worked in the Department of Anesthesiology, Stony Brook Medicine (NY, US) as a Research Scholar and is currently studying in the Department of Biochemistry, University of Cambridge, UK. He received the Excellent Exam-free Graduate School Recommendation (top 5% of the university) and the Undergraduate Scholarship from the Guangzhou University of Chinese Medicine, the First-class Graduate Scholarship from the Jinan University, and Academic Progress Award from the Anesthesia and Cancer Laboratory (Stony Brook Medicine). He is an associate editor of International Journal on Oncology and Radiotherapy (Skeena Publisher), an editorial board member of the Chronicles of Complementary, Alternative Integrative Medicine (GRF Publishers), Cell Biology (Science Publishing Group), Cancer Research Journal (Science Publishing Group), MedRead Journal of Cancer Science (MedRead Publishing Group), and Journal of Medicine and Biology (TRIDHA Society of Biology & Medicine). He serves as a peer reviewer for the Cell Communication and Signaling (BMC, IF 5.7), International Journal of Molecular Sciences (MDPI, IF 4.6), Life Sciences (ELSEVIER, IF 3.6), Molecules (MDPI, IF 3.3), Molecular Medicine Reports (Spandidos Publicatio, IF 1.9), Oncology Letters (Spandidos Publicatio, IF 1.9), Experimental and Therapeutic Medicine (Spandidos Publicatio, IF 1.5), Journal of Signa Vitae (MRE PRESS, IF 0.3), Molecular and Clinical Oncology (Spandidos Publicatio), Molecular and Clinical Oncology (Spandidos Publicatio), Archives of Surgery and Clinical Case Reports (Gavin publisher) and Archives of Cancer (Gavin publisher). During his early career, he studied the potential mechanism underlying the effect of Chinese traditional medicine on osteoporosis. Later on, in Stony Brook, his work has contributed to the understanding of the role of ion channel TRPM7 and anesthetics in cancer progression. His current study in Cambridge is focusing on the function and structure of voltage-gated sodium channels and the development of subtype-specific ion channel antibodies for pharmacological and cancer applications.
Traditional medicine, Cancer biology, Ion channels & Electrophysiology, Anesthesiology, Antibody Phage display